NCT02215707View on ClinicalTrials.gov

A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
Malaria
Interventions
BIOLOGICAL

PfSPZ Vaccine

Suspension of metabolically active, non-replicating (live), radiation-attenuated, purified, cryopreserved, aseptic Plasmodium falciparum (Pf) sporozoites (SPZ)

Trial Locations (1)

20910

Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center, Silver Spring

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

Military Infectious Diseases Research Program (MIDRP)

NETWORK

lead

Sanaria Inc.

INDUSTRY

NCT02215707 - A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses | Biotech Hunter | Biotech Hunter